The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital today announced its inaugural 2021 Inspiration Award recipient, Sandy Morris.
Healey Center News & Events
The annual Healey Center International Prize for Innovation in ALS is a global prize celebrating excellence in research for a team of investigators who catalyse exceptional discoveries leading to a transformative advance in therapy development in ALS.
People with ALS are known to have increased inflammatory changes in the muscle control regions of the brain (motor cortices) as learned from brain PET scan biomarkers and from postmortem studies. Clinical trials using smaller sample sizes and biomarker readouts are the need of the hour in early phase drug development in ALS.
The Gupta Family Endowed Prize for Innovation in ALS Care is a global prize to honor ground-breaking new approaches that lead to exceptional care for individuals living with amyotrophic lateral sclerosis (ALS).
Healey Center for ALS in partnership with ALS Finding a Cure announces the 2021 ALS Scholars in Therapeutics Recipients
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) in partnership with ALS Finding a Cure (ALSFAC) selected four recipients for their inaugural global two-year ALS Scholars in Therapeutics program.
Darlene Sawicki, MSN, NP-BC, became the first Mass General nurse formally recognized for the critical role nurses play in the lives of ALS patients and their families. Thanks to the generosity of the Richards family, Ms. Sawicki was named the incumbent of the new David Richards Endowed Nursing Chair.
Healey Center for ALS Passes 50% Participant Enrollment Milestone for First 3 Regimens in the HEALEY ALS Platform Trial
The HEALEY ALS Platform Trial, an initiative led by the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and conducted at sites of the Northeast ALS (NEALS) consortium, continues to gain momentum just months after launching in 2020, passing the 50% participant enrollment milestone for the first 3 regimens.
Revalesio signs agreement to design trial with RNS60 for the HEALEY ALS Platform Trial. Revalesio signs agreement to design trial with RNS60 for the HEALEY ALS Platform Trial. Key Takeaways • Investigators are planning to test the potential of
Healey Center Receives ALS Collaborative Cohort Grant to Enhance Access to Clinical Research and Trials
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital will join the new ALS Collaborative Cohort program with a grant from Tambourine, Ben and Divya Silbermann’s philanthropy. The Cohort consists of six US-based organizations that will work together to promote access and inclusion across the ALS landscape.
The HEALEY ALS Platform Trial team is launching a new webinar series to enable members of the ALS community to learn about the mechanism of action and science behind each of the drugs currently in testing in the Platform Trial.
Transforming Medicine Through Innovation
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.